Sharing product information just got easier along the entire agriculture and food value chain

PolyMedix, Inc, has received a Phase 2 grant in the amount of $986,000 from the National Institute of Health (NIH) to support the development of defensin mimetic antimicrobial compounds for the treatment of oral candidiasis.